Alzamend Neuro (ALZN) EBIT (2020 - 2026)
Alzamend Neuro (ALZN) reported EBIT of -$3.03 million for fiscal Q1 2027 (quarter ended Jul 31, 2026), compared with -$2.7 million a year earlier.
Powered by 
Analysis
Alzamend Neuro (ALZN) EBIT (2020 - 2026) Analysis & Trends
Over the twelve months ended Jul 31, 2026, Alzamend Neuro's EBIT came in at -$9.09 million; for FY2026 (ended Apr 30, 2026), it came in at -$8.77 million.
- By fiscal year, EBIT came in at -$4.5 million in FY2025, -$9.94 million in FY2024, -$14.87 million in FY2023 and -$12.32 million in FY2022.
- The fiscal Q1 2027 figure ranks as the lowest quarterly EBIT since fiscal Q1 2024.
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at -$2.87 million (Q4 2026), -$2.2 million (Q3 2026) and -$998,109 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.06 Bn | 1,102.65 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 616.49 Bn | 535.01 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 501.55 Bn | 474.66 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 367.24 Bn | 321.62 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 297.99 Bn | 261.98 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.48 Bn | 235.17 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 236.17 Bn | 191.57 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 190.68 Bn | 164.87 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 169.35 Bn | 115.99 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Alzamend Neuro | 5.73 Mn | -9.73 Mn | - | -3.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -3.03 Mn |
| Apr 30, 2026 | -2.87 Mn |
| Jan 31, 2026 | -2.20 Mn |
| Oct 31, 2025 | -998,109.00 |
| Jul 31, 2025 | -2.70 Mn |
| Apr 30, 2025 | -1.14 Mn |
| Jan 31, 2025 | -1.04 Mn |
| Oct 31, 2024 | -1.36 Mn |
| Jul 31, 2024 | -962,405.00 |
| Apr 30, 2024 | -850,064.00 |
| Jan 31, 2024 | -2.66 Mn |
| Oct 31, 2023 | -2.90 Mn |
| Jul 31, 2023 | -3.53 Mn |
| Apr 30, 2023 | -3.31 Mn |
| Jan 31, 2023 | -5.42 Mn |
| Oct 31, 2022 | -3.11 Mn |
| Jul 31, 2022 | -3.04 Mn |
| Apr 30, 2022 | -3.87 Mn |
| Jan 31, 2022 | -2.56 Mn |
| Oct 31, 2021 | -3.58 Mn |
API Access
Alzamend Neuro EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();